These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 35762296)
1. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting. Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT; Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296 [TBL] [Abstract][Full Text] [Related]
2. Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project). Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Troilius Rubin A; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT; J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1888-1895. PubMed ID: 34014582 [TBL] [Abstract][Full Text] [Related]
3. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'. Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB Trials; 2014 Jun; 15():247. PubMed ID: 24962012 [TBL] [Abstract][Full Text] [Related]
4. Development of a Core Outcome Set and Minimum Reporting Set for intervention studies in growth restriction in the NEwbOrN (COSNEON): study protocol for a Delphi study. Knol M; Wang H; Bloomfield F; Piet T; Damhuis S; Khalil A; Ganzevoort W; Gordijn S Trials; 2019 Aug; 20(1):511. PubMed ID: 31420053 [TBL] [Abstract][Full Text] [Related]
6. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals. van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO; Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177 [TBL] [Abstract][Full Text] [Related]
7. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness. Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT; Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299 [TBL] [Abstract][Full Text] [Related]
8. Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes. Millar AN; Daffu-O'Reilly A; Hughes CM; Alldred DP; Barton G; Bond CM; Desborough JA; Myint PK; Holland R; Poland FM; Wright D; Trials; 2017 Apr; 18(1):175. PubMed ID: 28403876 [TBL] [Abstract][Full Text] [Related]
9. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment. Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK; Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595 [TBL] [Abstract][Full Text] [Related]
10. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials. Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367 [TBL] [Abstract][Full Text] [Related]
11. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome. Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A; Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170 [TBL] [Abstract][Full Text] [Related]
12. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research. Oei W; Fledderus AC; Spuls PI; Eggen CAM; Kottner J; van der Horst CMAM; Wolkerstorfer A; van Kessel MS; Krengel S; Etchevers HC; Korfage IJ; Pasmans SGM Br J Dermatol; 2021 Aug; 185(2):371-379. PubMed ID: 33237568 [TBL] [Abstract][Full Text] [Related]
13. Core outcomes for pressure ulcer prevention trials: results of an international consensus study: Classification: Outcomes and qualitative research. Lechner A; Coleman S; Balzer K; Kirkham JJ; Muir D; Nixon J; Kottner J Br J Dermatol; 2022 Nov; 187(5):743-752. PubMed ID: 35789479 [TBL] [Abstract][Full Text] [Related]
14. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190 [TBL] [Abstract][Full Text] [Related]
15. Core outcome domains for clinical trials in non-specific low back pain. Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358 [TBL] [Abstract][Full Text] [Related]
16. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol. Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910 [TBL] [Abstract][Full Text] [Related]
17. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting. Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427 [TBL] [Abstract][Full Text] [Related]
18. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study. Tellum T; Naftalin J; Chapron C; Dueholm M; Guo SW; Hirsch M; Larby ER; Munro MG; Saridogan E; van der Spuy ZM; Jurkovic D Hum Reprod; 2022 Aug; 37(9):2012-2031. PubMed ID: 35906919 [TBL] [Abstract][Full Text] [Related]
20. Development of an international core outcome set for peripheral vascular malformations: the OVAMA project. Horbach SER; van der Horst CMAM; Blei F; van der Vleuten CJM; Frieden IJ; Richter GT; Tan ST; Muir T; Penington AJ; Boon LM; Spuls PI; Br J Dermatol; 2018 Feb; 178(2):473-481. PubMed ID: 28986976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]